Breast Cancer Clinical Trials in Montpellier
19 recruitingMontpellier, France
Showing 1–19 of 19 trials
Recruiting
Phase 3
Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Breast Cancer
UNICANCER3,902 enrolled70 locationsNCT07237256
Recruiting
Phase 3
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerAdvanced Breast Cancer+1 more
Olema Pharmaceuticals, Inc.510 enrolled233 locationsNCT06016738
Recruiting
Not Applicable
SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle500 enrolled1 locationNCT06053086
Recruiting
Not Applicable
Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle854 enrolled1 locationNCT06382818
Recruiting
Phase 3
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Hoffmann-La Roche450 enrolled210 locationsNCT06790693
Recruiting
Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
Breast Cancer
AstraZeneca625 enrolled315 locationsNCT06103864
Recruiting
Not Applicable
Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.
Breast Cancer
Institut Claudius Regaud120 enrolled25 locationsNCT05378204
Recruiting
Phase 3
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer
Breast Cancer
AstraZeneca100 enrolled40 locationsNCT07205822
Recruiting
REBECCA Real-world Early BrEast CanCer mAnagement
Breast Cancer
AstraZeneca126 enrolled44 locationsNCT06856343
Recruiting
Phase 1Phase 2
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Breast CancerMetastatic Breast Cancer
Stemline Therapeutics, Inc.435 enrolled118 locationsNCT05563220
Recruiting
Not Applicable
Feasibility and Acceptability of Endoscopic Mastectomy in Patients With Breast Cancer
Breast Cancer
University Hospital, Montpellier20 enrolled1 locationNCT06569706
Recruiting
Not Applicable
Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer
Breast CancerCognitive Dysfunction
Centre Francois Baclesse300 enrolled25 locationsNCT06027632
Recruiting
Not Applicable
Assessment the sExual Quality of Life in Breast Cancer Patients Receiving oncoSexology Supportive Care on Proactive Versus On-request
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle264 enrolled9 locationsNCT06415266
Recruiting
Not Applicable
Analysis of Circulating Tumor Markers in Blood
Breast CancerLung CancersSarcoma+3 more
Institut du Cancer de Montpellier - Val d'Aurelle992 enrolled2 locationsNCT04025541
Recruiting
Not Applicable
Development of Clinical and Biological Database
Breast CancerSarcomaGynecologic Cancer+1 more
Institut du Cancer de Montpellier - Val d'Aurelle4,000 enrolled1 locationNCT03449264
Recruiting
Phase 2
Improving Theempowerment in Patients With Severe Breast Fibrosis Radio-induced Treated by Pravastatin : Benefit of e-PROs (Electronic " Patient Reported Outcome ") on Breast-related Quality of Life
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle105 enrolled1 locationNCT04356209
Recruiting
Not Applicable
Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle25 enrolled1 locationNCT05056350
Recruiting
Not Applicable
Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery
Breast Cancer
University Hospital, Montpellier200 enrolled4 locationsNCT05350527
Recruiting
Not Applicable
Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction
Breast CancerCapsular Contracture Associated With Breast Implant
Institut du Cancer de Montpellier - Val d'Aurelle250 enrolled9 locationsNCT04342546